UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | 1.23 | 1.23 |
| Q1 2022 | 2022-05-10 | 1.14 | 1.14 |
| Q4 2021 | 2022-02-28 | 0.94 | 0.94 |
| Q3 2021 | 2021-11-09 | 0.88 | 0.88 |
| Q2 2021 | 2021-08-10 | 1.17 | 1.17 |
| Q1 2021 | 2021-05-11 | 0.91 | 0.91 |
| Q4 2020 | 2021-03-02 | 0.45 | 0.45 |
| Q3 2020 | 2020-11-03 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-05 | 0.39 | 0.39 |
| 2016-06-29 | Upgrade | Goldman Sachs | Neutral to Buy | $16.00 to $18.00 |
| 2016-06-29 | Upgrade | Goldman Sachs Group Inc. | Neutral to Buy | $16.00 to $18.00 |
| 2016-06-08 | Reiterated Rating | Canaccord Genuity | Buy | $18.00 |
| 2016-05-26 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $14.00 to $18.00 |
| 2016-05-12 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-04-08 | Reiterated Rating | Canaccord Genuity | Buy | $15.50 |
| 2016-04-01 | Lower Price Target | Avondale Partners | Market Outperform | $17.50 to $17.00 |
| 2016-03-07 | Reiterated Rating | Canaccord Genuity | Buy | $15.50 |
| 2016-03-03 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $11.00 to $12.00 |
| 2016-03-01 | Reiterated Rating | Canaccord Genuity | Buy | $15.50 |
| 2016-01-27 | Lower Price Target | JPMorgan Chase & Co. | $12.00 to $11.00 | |
| 2016-01-12 | Boost Price Target | BB&T Corp. | Buy | $18.00 |
| 2015-12-16 | Reiterated Rating | Roth Capital | Buy | $14.00 |
| 2015-11-16 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $11.00 to $12.00 |
| 2015-11-16 | Lower Price Target | BMO Capital Markets | Outperform | $22.00 to $20.00 |
| 2015-11-11 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 to $15.50 |
| 2015-10-28 | Initiated Coverage | JPMorgan Chase & Co. | Neutral | $11.00 |
| 2015-09-22 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 |
| 2015-09-01 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 |
| 2015-08-17 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 |
| 2015-08-12 | Reiterated Rating | Roth Capital | Buy | |
| 2015-07-30 | Reiterated Rating | Canaccord Genuity | Buy | $19.00 |
| 2015-07-14 | Initiated Coverage | BB&T Corp. | Buy | $17.00 |
| 2015-05-21 | Initiated Coverage | Roth Capital | Buy | $21.00 |
| 2015-05-12 | Lower Price Target | Canaccord Genuity | Buy | $21.00 to $19.00 |
| 2015-03-06 | Reiterated Rating | Goldman Sachs | Buy to Neutral | $24.00 to $17.00 |
| 2015-03-02 | Reiterated Rating | Canaccord Genuity | Buy | $21.00 |
| 2015-01-05 | Initiated Coverage | Off Wall Street | Long-term Buy | $25.00 |
| 2014-06-23 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | $25.00 to $20.66 |
| 2014-01-13 | Initiated Coverage | Goldman Sachs | Buy | $25.00 |
| 2013-12-23 | Initiated Coverage | BMO Capital Markets | Outperform | $25.00 |
| 2013-12-17 | Upgrade | Avondale Partners | Market Perform to Outperform | |
| 2013-11-18 | Downgrade | Wedbush | Outperform to Neutral | $26.00 to $20.00 |
| 2013-11-11 | Initiated Coverage | BMO Capital Markets | Market Perform | $19.00 to $24.00 |
| 2013-08-26 | Upgrade | Canaccord Genuity | Hold to Buy | $22 to $25 |
| 2012-11-12 | Downgrade | Ardour Capital | Buy to Hold | $19 to $17.50 |
| 2012-11-07 | Downgrade | Maxim Group | Buy to Hold | |
| 2012-11-05 | Downgrade | Avondale | Mkt Outperform to Mkt Perform | $18 |
| 2012-07-10 | Initiated | JMP Securities | Mkt Perform | |
| 2011-11-14 | Upgrade | Ardour Capital | Accumulate to Buy | $20 |
| 2011-05-16 | Upgrade | Morgan Joseph | Hold to Buy | $21 |
| 2011-03-04 | Reiterated | Maxim Group | Buy | $15 to $18 |
| 2010-11-17 | Initiated | Morgan Joseph | Hold | |
| 2010-06-02 | Upgrade | Ardour Capital | Hold to Accumulate | $9 to $9.50 |
| 2010-05-17 | Reiterated | Jesup & Lamont | Buy | $9.25 to $9.75 |
| 2010-03-19 | Reiterated | Maxim Group | Buy | $10 to $12 |
| 2010-02-19 | Initiated | Jesup & Lamont | Buy | $10 |
| 2009-05-18 | Reiterated | Avondale | Mkt Outperform | $7.50 to $9 |
| 2009-05-18 | Downgrade | Ardour Capital | Accumulate to Hold | $4 to $7 |
| 2009-05-13 | Reiterated | Maxim Group | Buy | $6 to $10 |
| 2009-04-29 | Downgrade | Standpoint Research | Buy to Hold | |
| 2009-03-06 | Reiterated | Maxim Group | Buy | $10 to $6 |
| 2008-12-11 | Initiated | Canaccord Adams | Buy | $5.75 |
| 2016-06-29 | Upgrade | Goldman Sachs | Neutral to Buy | $16.00 to $18.00 |
| 2016-06-29 | Upgrade | Goldman Sachs Group Inc. | Neutral to Buy | $16.00 to $18.00 |
| 2016-06-08 | Reiterated Rating | Canaccord Genuity | Buy | $18.00 |
| 2016-05-26 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $14.00 to $18.00 |
| 2016-05-12 | Reiterated Rating | Canaccord Genuity | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In DAR 364 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 17.80M |
| Vanguard Group, Inc | 16.25M |
| BlackRock Fund Advisors | 13.36M |
| FMR LLC | 6.52M |
| STATE STREET CORP | 4.59M |
| BlackRock Institutional Trust Company, N.A. | 4.29M |
| GW CAPITAL INC | 3.94M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.81M |
| EARNEST PARTNERS LLC | 3.54M |
| DEUTSCHE BANK AG\ | 3.48M |
| DAVIS SELECTED ADVISERS | 3.18M |
| DIMENSIONAL FUND ADVISORS LP | 2.96M |
| FIL Ltd | 2.81M |
| Grantham, Mayo, Van Otterloo & Co. LLC | 2.27M |
| Impax Asset Management LTD | 2.13M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| STUEWE RANDALL C Chairman and CEO | 0.80% (1319946) | DAR / |
| Griffin Martin W. See Remarks | 0.22% (360390) | DAR / |
| Griffin Robert A. Pres of Griffin Industries | 0.16% (265656) | DAR / |
| STERLING JOHN F EVP, General Counsel and Sec. | 0.14% (225861) | DAR / |
| Carlson C Dean | 0.11% (188813) | DAR / |
| KATCHEN NEIL EVP-COO Retail and Service | 0.09% (154337) | DAR / |
| Kloosterboer Dirk Chief Operating Off - Dar Intl | 0.09% (151858) | DAR / |
| LYNCH PATRICK C EVP - Chief Admin Officer | 0.09% (147295) | DAR / TILE / |
| Bullock John EVP - Chief Strategy Officer | 0.08% (129488) | DAR / |
| Stevenson Colin EVP - Chief Financial Officer | 0.05% (79202) | DAR / |
| MACALUSO CHARLES | 0.05% (74132) | DAR / GLPW / |
| Elrod Rick A EVP - Dar Pro USA | 0.04% (70633) | DAR / |
| ALBRECHT THOMAS | 0.04% (66832) | DAR / |
| MUSE JOHN O EVP- Finance and Admin | 0.04% (58627) | DAR / |
| PHILLIPS BRAD Treasurer | 0.03% (54717) | DAR / |
| Urbut Michael | 0.03% (51035) | DAR / |
| van der Velden Jan Executive Vice President - ERS | 0.03% (48359) | DAR / |
| Seemann Robert H EVP - Sales and Services | 0.02% (39065) | DAR / |
| Ewing D Eugene | 0.02% (33886) | CODI / DAR / |
| March John D. | 0.02% (33146) | BIOF / DAR / |
| Korby Mary R | 0.01% (22858) | DAR / |
| SNELL BRENDA Chief Accounting Officer | 0.01% (20434) | DAR / |
| Sanders Justinus | 0.01% (17550) | DAR / |
| PHARR CYNTHIA | 0.01% (13500) | CEC / DAR / |
| Mize Gary W. | 0.01% (13300) | DAR / GEVO / |
| RESCOE MICHAEL E | 0.01% (9490) | DAR / GLPW / |
UM